Concentric UV Irradiation Apparatus for Perfusion Fluid Sterilization

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

There is an insufficient number of suitable donor organs for transplantation, particularly due to the high risk of microorganism transmission, such as hepatitis C virus (HCV), from donor lungs to recipients.

Innovation Solution

The use of ex vivo perfusion (EVP) combined with light therapy, specifically UVC irradiation or photodynamic therapy (PDT), to inactivate microorganisms in the perfusate of donor organs, thereby reducing the viral or bacterial load and increasing organ availability for transplantation.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Quantity of substance

If donor organs from HCV+ donors are used for transplantation, then organ availability increases, but the risk of virus transmission to recipients increases

Engineering Contradiction:
Improveorgan availabilityVSAvoidvirus transmission risk
Core Design Contradiction:
Quantity of substanceVSObject-affected harmful factors

Solution Approach 1:

The patent applies preliminary action by performing UVC irradiation or photodynamic therapy on the donor organ before transplantation to inactivate viruses and microorganisms in advance, thereby reducing transmission risk while maintaining organ availability

Inventive Principle:
Principle #10Preliminary action

Solution Approach 2:

The patent converts the harmful effect of light (which can damage biological tissues) into a beneficial effect by using controlled UVC irradiation or photodynamic therapy to inactivate pathogens, transforming a potential harm into a protective measure that enables safer organ transplantation

Inventive Principle:
Principle #22Blessing in disguise (Convert harm into benefit)

2Reliability

If light therapy (UVC irradiation or PDT) is applied to inactivate microorganisms in perfusate, then virus inactivation efficacy increases, but device complexity increases

Engineering Contradiction:
Improvevirus inactivation efficacyVSAvoidirradiation system complexity
Core Design Contradiction:
ReliabilityVSDevice complexity

Solution Approach 1:

The patent extracts the light source from the main EVLP system by using an external irradiation device that can be applied to the organ or perfusate separately, thereby reducing the complexity of the integrated system while maintaining inactivation efficacy

Inventive Principle:
Principle #2Taking out (Extraction)

Solution Approach 2:

The patent uses an intermediary approach by employing a photosensitizer in photodynamic therapy that mediates between the light source and the virus, allowing indirect inactivation through reactive oxygen species generation, which reduces direct exposure complexity

Inventive Principle:
Principle #24Intermediary (Mediator)

3Reliability

If ex vivo perfusion is used to treat donor organs, then organ viability assessment and treatment capability improve, but treatment time increases

Engineering Contradiction:
Improveorgan viability assessmentVSAvoidtreatment time
Core Design Contradiction:
ReliabilityVSLoss of time

Solution Approach 1:

The patent merges the virus inactivation process with the existing EVLP treatment protocol, allowing simultaneous organ assessment and pathogen inactivation during the same perfusion period, thereby improving reliability without proportionally increasing treatment time

Inventive Principle:
Principle #5Merging (Combining)

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

This approach effectively decreases and/or inactivates microorganisms in donor organs, enhancing their safety for transplantation and potentially increasing the number of available organs by reducing the risk of pathogen transmission.

Implementation Method 1

a UV radiation-emitting device disposed inside the second chamber for providing irradiation to the perfusate

Methodology Applied
Scientific EffectUV irradiation: Light

Implementation Method 2

providing a photosensitizer in the perfusate and providing irradiation to the perfusate

Methodology Applied
Scientific EffectPhotodynamic therapy: Photo-oxidation

Data Source

PatentUS12207651B2Apparatus and methods for irradiating organ perfusates
Publication Date: 2025.01.28 UNIV HEALTH NETWORK
  • US12207651B2 patent drawing
  • US12207651B2 patent drawing
  • US12207651B2 patent drawing

AI summary

Disclosed are apparatuses and methods for irradiating a perfusate. The apparatus includes a tank which defines a first chamber. A separator is located inside the first chamber. The separator defines a second chamber. The first chamber and the second chamber are concentric and have substantially annular cross sections, each having at least one diameter and a substantially common longitudinal axis. A perfusate is introduced into the first chamber by an inlet. A UV radiation-emitting device is disposed inside the second chamber for providing irradiation to the perfusate. Irradiated perfusate is removed from the tank by an outlet. Other apparatuses and systems are described and methods for inactivating micro organisms by performing EVP and irradiating the perfusate.